Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 192,032 shares at $61.98 ($11.1M) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Open-market sale of $11.1M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.50 | 55,768 | $3.2M | 28.9% |
| 2 | $58.08 | 33,045 | $1.9M | 17.3% |
| 3 | $58.08 | 33,045 | $1.9M | 17.3% |
| 4 | $59.40 | 2,731 | $162K | 1.5% |
| 5 | $59.40 | 2,731 | $162K | 1.5% |
| 6 | $60.82 | 1,000 |
| $61K |
| 0.5% |
| 7 | $61.98 | 1,034 | $64K | 0.6% |
| 8 | $61.98 | 1,034 | $64K | 0.6% |
| 9 | $56.01 | 3,988 | $223K | 2.0% |
| 10 | $56.01 | 3,988 | $223K | 2.0% |
| 11 | $57.21 | 18,903 | $1.1M | 9.8% |
| 12 | $57.21 | 18,903 | $1.1M | 9.8% |
| 13 | $58.08 | 7,331 | $426K | 3.8% |
| 14 | $58.08 | 7,331 | $426K | 3.8% |
| 15 | $58.69 | 1,200 | $70K | 0.6% |
| Total | $57.75 avg | 192,032 | $11.1M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |